LIQENZA
Live / Allowed — Notice of allowance issued (as of 13 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99037296
- Mark type
- Stylized text
- Filed
- 11 Feb 2025
- Published for opposition
- 18 Nov 2025
- Attorney of record
- Dermot Horgan
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for the treatment of prostate cancer; Pharmaceutical preparations for the treatment of prostate cancer
Owner
- ZYDUS PHARMACEUTICALS (USA) Inc., Pennington, NJ, US
- ZYDUS PHARMACEUTICALS (USA) Inc., Pennington, NJ, US
Prosecution history
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Jul 2025 — NON-FINAL ACTION E-MAILED
- 22 Jul 2025 — NON-FINAL ACTION WRITTEN
- 20 Jul 2025 — ASSIGNED TO EXAMINER
- 20 Feb 2025 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 20 Feb 2025 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 20 Feb 2025 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED